Heron Therapeutics Inc 2020 Conference Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Heron Therapeutics conference call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) Now I would like to turn the call over to David Szekeres, Chief Legal, Business and Administrative Officer. Please proceed, sir.
Thank you, Michelle. Good afternoon, everyone, and thank you for joining us. With me today from Heron are Barry Quart, President and Chief Executive Officer; Kimberly Manhard, Executive Vice President, Drug Development; and John Poyhonen, Chief Commercial Officer.
Before we begin, I would like to remind you that this call will contain forward-looking statements concerning Heron's future expectations, plans, prospects, corporate strategy and performance, which constitute forward-looking statements for the purposes of the safe harbor provision under the Private Securities Litigation Reform Act of 1995. Actual results may
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
